Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline
Trial Miss Might Change The Case For Investing In BioNTech Stock (BNTX)
BioNTech SE Sponsored ADR $BNTX Shares Acquired by Assenagon Asset Management S.A.
BioNTech (NASDAQ:BNTX) Stock Gets Price Target Reduction from Canaccord Genuity Group - Markets Daily
Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
BioNTech (BNTX), What Is Behind The Latest Attention?
BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX) | Morningstar
Canaccord Genuity Group Has Lowered Expectations for BioNTech (NASDAQ:BNTX) Stock Price
BioNTech (NASDAQ:BNTX) Stock Price Target Cut by Canaccord Genuity Group - Daily Political
BioNTech (BNTX) Is Down 7.0% After mRNA Cancer Trial Misses PFS Goal Has The Bull Case Changed?
Critical Analysis: MiMedx Group (NASDAQ:MDXG) vs. BioNTech (NASDAQ:BNTX) - Daily Political
BioNTech's mRNA Cancer Therapy Fails Key Trial Objective in Head and Neck Cancer, ETPharma
What Does BioNTech (BNTX) Trial Miss Mean For Its Oncology Pipeline?
Sivik Global Healthcare LLC Makes New $2.16 Million Investment in BioNTech SE Sponsored ADR $BNTX
BioNTech (NASDAQ:BNTX) Shares Down 5.5% - Here's What Happened
BioNTech mRNA cancer immunotherapy misses first objective in key study
BioNTech Shares Fall 5% as BNT113 Cancer Trial Misses Progression-Free Survival Endpoint
BioNTech stock falls after cancer trial misses key endpoint
BioNTech's BNT113 Misses Progression-Free Survival Endpoint In Phase 3 Head And Neck Cancer Trial
BioNTech Continues AHEAD-MERIT Trial Despite BNT113's PFS Endpoint Miss
Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick?
BioNTech (NASDAQ:BNTX) Research Coverage Started at Argus - Stock Observer
BioNTech (NASDAQ:BNTX) CEO Sells $2,300,640.00 in Stock - Markets Daily
BioNTech (NASDAQ:BNTX) CEO Sells 27,000 Shares of Company Stock - Markets Daily
BioNTech (NASDAQ: BNTX) CEO sells all direct shares under trading plan - Stock Observer
Moderna stock jumps on planned national cancer vaccine effort
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
12,163 BioNTech SE Sponsored ADR $BNTX Shares Sold by Crocodile Capital Partners GmbH - Daily Political
Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells $7,000,560.00 in Stock - Daily Political
BioNTech (NASDAQ:BNTX) Now Covered by Argus
BioNTech (NASDAQ:BNTX) Stock Picked Up by Analysts at Argus - Zolmax
Is BioNTech (BNTX) Undervalued On Pipeline Promise Despite Revenue Of €2,650.0 Million And Losses?
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Stock Now Rated "Moderate Buy" by Wall Street Analysts - Daily Political
BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 24,000 Shares of Stock
Is BioNTech (NasdaqGS:BNTX) Overvalued As Sales Face A Reset?
BNTX Maintained by Morgan Stanley -- Price Target Lowered to $11
BioNTech (NASDAQ: BNTX) CEO sells 93,000 shares under preplanned deal - Markets Daily
BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 72,000 Shares
Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?
BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 72,000 Shares of Company Stock - Stock Observer
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Stock Has Average Price Target of $126.00 According to Brokerages - Markets Daily
Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up
Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Stock Has Consensus Target Price of $126.00
BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 17,000 Shares
Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water
BioNTech (NASDAQ:BNTX) CEO Sells $2,664,630.00 in Stock - Markets Daily
BioNTech (NASDAQ:BNTX) CEO Sells $3,347,980.00 in Stock - Stock Observer
BioNTech CEO sold shares under plan - Stock Observer
BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 32,000 Shares of Stock
BioNTech Closes Manufacturing Sites in Germany and Singapore Amidst Failed Sales, ETPharma
BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 27,000 Shares
BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 34,000 Shares
How New Lung Cancer Data And Updated COVID Shot At BioNTech (BNTX) Has Changed Its Investment Story
Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)
BioNTech (NasdaqGS:BNTX) Stock May Look Fully Valued On Fresh Lung Cancer Trial Data
BioNTech co-founders name new pharmaceutical company 'Arife' - Türkiye News
BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 30,000 Shares
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 39,000 Shares - Stock Observer
BioNTech (NASDAQ:BNTX) CEO Sells 46,000 Shares of Stock
Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells $4,633,120.00 in Stock - Zolmax
BioNTech (NASDAQ:BNTX) CEO Sells 33,000 Shares
Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up?
Biontech Se (BNTX) - Insider Monkey
Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher
BioNTech (BNTX) Could Be 19% Undervalued On Vaccine Approval And Phase 3 Data
Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells $3,280,660.00 in Stock - Markets Daily
Ugur Sahin Sells 34,000 Shares of BioNTech (NASDAQ:BNTX) Stock
BioNTech News
CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?
Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?
Eli Lilly Stock Forecast 2026–2030: Can LLY Break Above $1,300 After Its 7% Five-Session Rally?
Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks
Latest news
Show more
USD/JPY Holds Near 158 as Intervention Risk Caps Gains and Fed Hike Bets Ease
Meta Earnings Preview: Can AI Growth Restore Confidence After the Nasdaq Sell-Off?
Nasdaq Falls 4.48% as AI Debt Concerns Shake Tech Stocks; US Futures Rebound
Gold Price Forecast This Week: Can XAU/USD Reclaim $4,200 as Fed Rate-Hike Risks Persist?
Tesla Earnings Preview: Can Strong Deliveries Offset Rising Robotaxi and AI Costs?
